DTPA Scan, also called a Renal Dynamic Scan or Dynamic Renography, is a nuclear medicine test used to evaluate kidney function and urine flow.
DTPA stands for Diethylene Triamine Pentaacetic Acid. It is labeled with a small radioactive tracer called Technetium-99m (99mTc). The compound 99mTc-DTPA is filtered only by the glomeruli of the kidneys.
Because of this property, the test is highly useful for measuring the Glomerular Filtration Rate (GFR) and detecting urinary obstruction or impaired kidney function. During the scan, GFR is often calculated automatically, which is why the test is commonly referred to as a DTPA Scan with GFR.
The scan is non-invasive, safe, and can be performed in both adults and children. It is particularly helpful when doctors suspect urinary obstruction, hydronephrosis (swelling of the kidney), or unequal kidney function.
What is a DTPA Scan?
A DTPA scan is a nuclear medicine test that provides real-time imaging of kidney function. After injection, the tracer is taken up, filtered, and excreted through the kidneys.
The scan helps doctors evaluate:
Blood perfusion to the kidneys.
Filtration efficiency of each kidney (glomerular filtration).
The movement of urine from the kidneys to the bladder.
The test is particularly helpful for diagnosing urinary obstruction, reduced kidney function, and differences in the function of the two kidneys.
Key Terms Used
99mTc-DTPA
A radioactive tracer used in the scan.
Renal Dynamic Scan (RDS)
Another name for a DTPA scan, emphasizing its real-time dynamic imaging.
Dynamic Renography
A nuclear medicine technique used to evaluate kidney function and urine drainage.
DTPA with GFR
Refers to a DTPA scan where the glomerular filtration rate is calculated during the test.
Indications for a DTPA Scan
Doctors may recommend this scan in the following situations:
Assessment of urinary obstruction – to evaluate blockage in the urinary tract.
Estimation of GFR – an important indicator of overall kidney function.
Evaluation of renal drainage – to assess how urine flows from kidneys to ureters and bladder.
Baseline kidney function assessment – before treatments that may affect kidney function (e.g., chemotherapy).
Monitoring kidney function over time – particularly in patients with Chronic Kidney Disease (CKD).
Hydronephrosis evaluation – to determine whether dilation is obstructive or non-obstructive.
Post-surgical evaluation – after procedures such as pyeloplasty, ureteric stenting, or kidney transplantation.
Pediatric urology cases – evaluation of congenital kidney abnormalities in children.
Solitary kidney assessment – to ensure proper function of a single kidney.
Detection of silent urinary obstruction – especially when found incidentally on other imaging tests.
What Does a DTPA Scan Show?
The scan provides detailed information about:
Blood flow to the kidneys.
How effectively each kidney filters waste.
The functional contribution of each kidney.
Urinary drainage from kidneys to the bladder.
Presence of urinary obstruction.
Whether a blockage is reversible (often tested with a diuretic study).
Early signs of kidney dysfunction before symptoms appear.
Benefits of the DTPA Scan
Non-invasive and painless.
Provides real-time evaluation of kidney function.
Accurate measurement of GFR.
Helps differentiate between obstructive and non-obstructive kidney swelling.
Suitable for both adults and children.
May help avoid unnecessary surgery by confirming whether obstruction is significant.
Assists in treatment planning and long-term monitoring.
Conclusion
The DTPA Renal Dynamic Scan (Dynamic Renography) is an important nuclear medicine test that provides real-time evaluation of kidney function using 99mTc-DTPA. It allows doctors to accurately measure GFR and detect kidney obstruction, hydronephrosis, and functional differences between the kidneys.
Because it is safe, reliable, and highly informative, the DTPA scan remains a preferred diagnostic test for evaluating suspected or known kidney problems.
Test Information:
Patients are usually advised to eat normally and drink adequate water before the scan, unless instructed otherwise by their doctor.
Test information: Have food and good water intake if not restricted
Reporting: Within 12-24 Hrs
There is no restriction on food intake. Before the test, please have your breakfast and drink adequate water (5-10 mL/Kg of body weight within 30-60 minutes).
Please carry all medical documents, including doctor referral, Ultrasound report if any, blood test reports for Kidney function evaluation if any, etc. • Female patients are to inform their status of pregnancy and lactation.
The duration of the test varies for every individual. The first part, which extends around 30 minutes, is the same for all. But, delayed images such as 02, 04 & 24 hours vary from patient to patient and depend upon tracer clearance from kidneys.
भोजन के सेवन पर कोई प्रतिबंध नहीं है, कृपया अपना नाश्ता करें और परीक्षण से पहले पर्याप्त पानी (30-60 मिनट के भीतर शरीर के वजन का 5-10 एमएल/किलोग्राम) पिएं।
कृपया डॉक्टर रेफरल, अल्ट्रासाउंड रिपोर्ट, यदि कोई हो, किडनी फंक्शन मूल्यांकन के लिए रक्त परीक्षण रिपोर्ट, यदि कोई हो, आदि सहित सभी चिकित्सा दस्तावेज साथ रखें।
महिला रोगियों को अपनी गर्भावस्था और स्तनपान की स्थिति के बारे में सूचित करना होता है।
प्रत्येक व्यक्ति के लिए परीक्षण की अवधि अलग-अलग होती है। पहला भाग जो लगभग 30 मिनट का है, सभी के लिए समान है। लेकिन, 02, 04 और 24 घंटे जैसी विलंबित छवियां रोगी से रोगी में भिन्न होती हैं और गुर्दे से ट्रेसर निकासी पर निर्भर करती हैं।
After registration and payment, the patient's medical history is taken, including checking referral, treatment and investigation records, history of last meal, hydration, etc. Informed consent is also obtained at the same time.
An intravenous cannula is fixed, and injection medicine is prepared parallelly.
Patient is asked to pass urine before coming to the imaging table. An intravenous injection is given, and sequential dynamic images are acquired for 25-30 minutes.
Delayed images at 02, 04 or 24 hours post injection may be taken depending upon case to case.
Test may complete from 30 minutes to 24 hours, depending on the patient.
* For details, please see service-related policies